机器人辅助根治性肾切除术联合下腔静脉癌栓取出术十年:围手术期结局的系统综述与Meta分析
该系统综述与Meta分析纳入28篇文章共1375例患者,评估机器人辅助根治性肾切除术联合下腔静脉癌栓取出术(R-CT)的围手术期结局,并与开放手术(O-CT)比较。R-CT组输血率38.2%、总体并发症率30.3%;与O-CT相比,R-CT输血率更低(18.4% vs 64.3%,p=0.002)、总体并发症率更低(14.5% vs 36.7%,p=0.005),两组主要并发症和30天死亡率相似。作者认为在经验丰富的术者和严格筛选的患者中R-CT可行且安全,但选择偏倚限制确定性推断,最佳患者选择标准尚待描述。
要点
- R-CT单臂研究329例中,I级癌栓14.7%、II级60.9%、III级20.4%、IV级2.5%。
- R-CT对比O-CT:输血率18.4% vs 64.3%(p=0.002),总体并发症率14.5% vs 36.7%(p=0.005)。
- 两组主要并发症和30天死亡率相似,但选择偏倚限制确定性推断。
核心结论
- R-CT在严格筛选的患者中围手术期结局可接受。
- 与O-CT相比,R-CT与更低的输血率和更少的总体并发症相关。
- 在经验丰富的术者和严格筛选的患者中,R-CT可行且安全、结局可接受;但选择偏倚限制确定性推断,最佳患者选择标准尚待描述。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Scopus、Cochrane Central Register of Controlled Trials和Web of Science数据库,检索词包括肾细胞癌、下腔静脉、血栓形成或血栓、机器人、血栓取出术。
- 按照PRISMA指南进行,纳入报告R-CT围手术期结局的研究及比较R-CT与O-CT的研究。
- 检索获得28篇文章描述R-CT,其中7篇为比较研究;共纳入1375例患者,单臂研究329例,比较研究1046例。
主要发现
- 329例接受R-CT的患者中,I级癌栓14.7%、II级60.9%、III级20.4%、IV级2.5%。
- R-CT手术时间范围150至530分钟;输血率38.2%(126例);总体并发症率30.3%(99例)。
- R-CT对比O-CT:输血率18.4% vs 64.3%(p=0.002),总体并发症率14.5% vs 36.7%(p=0.005)。
- 两组主要并发症率和30天死亡率相似。
临床怎么用
- 作者认为,在经验丰富的术者和严格筛选的患者中,R-CT可行且安全、结局可接受;但选择偏倚限制确定性推断,最佳患者选择标准尚待描述。
局限性
- 选择偏倚限制确定性推断。
- 最佳患者选择标准尚待描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Open radical nephrectomy with inferior vena cava thrombectomy (O-CT) is standard management for renal cell carcinoma with inferior vena cava thrombus. First reported a decade ago, robotic-assisted radical nephrectomy with inferior vena cava thrombectomy (R-CT) is a minimally invasive option for this disease. We aimed to perform a systematic review to assess the safety and feasibility of R-CT in terms of perioperative outcomes and compare the outcomes between R-CT and O-CT. MATERIALS AND METHODS: The PubMed®, Scopus®, Cochrane Central Register of Controlled Trials and Web of ScienceTM databases were searched using the free-text and MeSH terms "renal cell carcinoma," "inferior vena cava," "thrombosis" or "thrombus," "robot" and "thrombectomy." Studies reporting perioperative outcomes of R-CT and studies comparing R-CT with O-CT were included. The review was done in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. RESULTS: The search retrieved 28 articles describing R-CT, including 7 comparative studies. This systematic review included 1,375 patients, out of which 329 patients were in single-arm studies and 1,046 patients were in comparative studies. Of the 329 patients who underwent R-CT, 14.7% were level I, 60.9% level II, 20.4% level III and 2.5% level IV thrombus. Operative time ranged from 150 to 530 minutes; blood transfusion was administered in 38.2% (126). The overall complication rate was 30.3% (99). R-CT, in comparison to O-CT, was associated with a lower blood transfusion rate (18.4% vs 64.3%, p=0.002) and a lower complication rate (14.5% vs 36.7%, p=0.005). Major complication and 30-day mortality rates were similar in both groups. CONCLUSIONS: R-CT has acceptable perioperative outcomes in carefully selected patients. Compared with O-CT, R-CT is associated with a lower blood transfusion rate and fewer overall complications. In experienced hands with carefully selected patients, R-CT is feasible and safe, with acceptable outcomes; however, selection bias limits definitive inference of these results, and optimal patient selection criteria remain to be described.
引用
- Garg H, Psutka SP, Hakimi AA, et al. A Decade of Robotic-Assisted Radical Nephrectomy with Inferior Vena Cava Thrombectomy: A Systematic Review and Meta-Analysis of Perioperative Outcomes. J Urol. 2022. PMID: 35762219. doi:10.1097/JU.0000000000002829
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。